| Gregory William Mallek, MD | |
|
364 Se 8th Ave, Suite 205, Hillsboro, OR 97123-4253 | |
| (503) 681-4145 | |
| Not Available |
| Full Name | Gregory William Mallek |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 364 Se 8th Ave, Hillsboro, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003012303 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD151488 (Oregon) | Primary |
| Entity Name | Good Shepherd Health Care System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295789667 PECOS PAC ID: 9133033764 Enrollment ID: O20031118000046 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) - an approach approved by the FDA in 2006 - did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare, a new study by Dana-Farber Cancer Institute researchers has found.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.
House Energy and Commerce Committee Democrats countered GOP claims that the health law is driving up insurance premiums by analyzing initial rate filings in five states.
› Verified 3 days ago
| Entity Name | Tuality Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) - an approach approved by the FDA in 2006 - did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare, a new study by Dana-Farber Cancer Institute researchers has found.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.
House Energy and Commerce Committee Democrats countered GOP claims that the health law is driving up insurance premiums by analyzing initial rate filings in five states.
› Verified 3 days ago
| Entity Name | Northwest Women's Clinic, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043204225 PECOS PAC ID: 4183610447 Enrollment ID: O20040422000212 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) - an approach approved by the FDA in 2006 - did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare, a new study by Dana-Farber Cancer Institute researchers has found.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.
House Energy and Commerce Committee Democrats countered GOP claims that the health law is driving up insurance premiums by analyzing initial rate filings in five states.
› Verified 3 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) - an approach approved by the FDA in 2006 - did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare, a new study by Dana-Farber Cancer Institute researchers has found.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.
House Energy and Commerce Committee Democrats countered GOP claims that the health law is driving up insurance premiums by analyzing initial rate filings in five states.
› Verified 3 days ago
| Entity Name | Obhg Oregon Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528585148 PECOS PAC ID: 2365776390 Enrollment ID: O20190626000182 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) - an approach approved by the FDA in 2006 - did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare, a new study by Dana-Farber Cancer Institute researchers has found.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.
House Energy and Commerce Committee Democrats countered GOP claims that the health law is driving up insurance premiums by analyzing initial rate filings in five states.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory William Mallek, MD 364 Se 8th Ave, Suite 205, Hillsboro, OR 97123-4253 Ph: (503) 681-4145 | Gregory William Mallek, MD 364 Se 8th Ave, Suite 205, Hillsboro, OR 97123-4253 Ph: (503) 681-4145 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) - an approach approved by the FDA in 2006 - did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare, a new study by Dana-Farber Cancer Institute researchers has found.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.
House Energy and Commerce Committee Democrats countered GOP claims that the health law is driving up insurance premiums by analyzing initial rate filings in five states.
› Verified 3 days ago
Dr. Katherine Ann Brown, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1575 Ne Arrington Rd, Hillsboro, OR 97124 Phone: 503-693-0113 Fax: 503-681-4773 | |
Christine Marie Corbin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4660 Ne Belknap Ct, Suite 109, Hillsboro, OR 97124 Phone: 503-693-1944 Fax: 503-693-1941 | |
Sarah Rose Jordan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5880 Ne Cornell Rd, Suite C, Hillsboro, OR 97124 Phone: 971-228-8097 Fax: 503-681-4146 | |
Molly Renee Wilson-smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7431 Ne Evergreen Pkwy Ste 100, Hillsboro, OR 97124 Phone: 503-840-3400 Fax: 503-840-3409 | |
Julie Ann Olds, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 364 Se 8th Ave, Suite 205, Hillsboro, OR 97123 Phone: 503-681-1690 Fax: 503-681-1608 | |
Dr. Kathleen Casey Dalke, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2875 Nw Stucki Ave, Hillsboro, OR 97124 Phone: 971-310-3510 Fax: 971-310-3161 |